Thinking something like this.. Follow the links in my bio for the full video.
LABU is showing really good support. It's currently in a decline but should hold at $48.95 ish with a bounce and possible triangular breakout.
next target is of 59.15 and looking good for the long term too.
The most attractive part of WAVE.V is share structure: 54M total float with 41M shares held by insiders / escrowed, leaving about 13M shares free trading. The company owns a portfolio of generic oncology drugs from which it generates over $300K of quarterly revenue. $1M in cash on hand. Based on last financials, they are $83K away from generating positive cash...
Well, atleast the charts say so.The stock on the weekly horizon is making an Inverted Head and Shoulders, the target for which comes to be about 680 odd levels. On the daily horizon, the stock is well above the key EMAs. Besides, the price shows no divergence with respect to the RSI and Stochastics. This post is solely for education purpose.
FA: Earings release- the last earnings where the estimate was higher than 0.05 per share it led to the stock rallying by 40%- unless, the earings surprise is a negative one; we can expect a rally from Vanda Pharmaceuticals. TA: Currently been trading in a limited channel- lack of momentum could lead to a dump if earnings estimate is negative or perhaps mean no...
TORNTPHARMA SWING AND BREAKOUT TRADING IDEA FRIENDS IF YOU LIKE THEN PLEASE LIKE AND SHARE.
Formations drawn Rising Wedge Scythe I expect a breakdown of this weird wedge that has formed between a major trendline and a line of strong bounce areas
it was looking poised to reach 270-75 but got some pullbacks in past few weeks, it's looking strong technically and fundamentally (if it also gets some share in the development of vaccine) now though.
I think this is probably where I will place bids on NOVN.. Still looking weak AF right now.
Wedge formation taking place target -940 b/w 2-3 days stoploss- 900 if trendline get break then can get level at 880
Hey everyone, Biocon is still a good buy 350-365 range for Long term Investment. Target should be 520 in the year 2020. Stock Momentum is good in upside and can be considered to add in any Portfolio.
🧑⚕️ Pfizer recently announced that a clinical trial of its drug Ibrance hasn't worked out as a long-term treatment for breast cancer. This news is unfortunate on a few levels, but specifically, in terms of price, the impact isn't great. Upon releasing the news PFE dumped as analyst began to revise earnings expectations downward. This sell-off caused a reversal of...
All, I think we are coming to a double bottom soon. The weekly on QLGN it's obvious there was a massive double top + merger made it sail down. The Question here is where does it end? It is essentially down over 45%. It is going to hit that trend line coming down and most likely fail if you want to swing that. Overall it will recover just a matter of how long. **...
NASDAQ:EVFM 😊Please LIKE & FOLLOW for more VIP Hunters signals , penny stocks FDA date of approval - 25th of May Our Strategy with this Stock : This company is a silent player in beer bug vaccination , I'm keeping an eye on it due to the strong upper trend of the company. I'm putting two alarms, one at 2.99 to monitor any anticipatory run up. I'm...
Stock is making higher top and higher bottom on daily chart. Stock has took support at 21 Day EMA and showing reversal from support. ADX is also giving positive cross over. We are recommending Buy around 2330-2340 with Stop Loss of 2250 (Closing Basis) for Target of 2470 in next 8-10 Days.
NASDAQ:AQST 😊Please LIKE & FOLLOW for more VIP Hunters signals , penny stocks Our Strategy with this Stock : the company will release the drug for Parkinson disease treatment, The analysts are writing the stock at $17 to drive the sheep to buy the stock , while safe Traders will look for a high price of 6.18 $ . I'm putting two alarms, one at 4.79 to...